RIM
SUPN icon

Ranger Investment Management’s Supernus Pharmaceuticals SUPN Stock Holding History

Ranger Investment Management’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-468,796
Closed -$15.5M – 124
2019
Q2 		$15.5M Sell
468,796
-4,955
-1% -$170K 1.06% 42
2019
Q1 		$16.6M Buy
473,751
+55,718
+13% +$2.07M 1.2% 41
2018
Q4 		$13.9M Sell
418,033
-182,431
-30% -$7.84M 1.13% 38
2018
Q3 		$30.2M Buy
600,464
+131,531
+28% +$6.5M 2% 22
2018
Q2 		$28.1M Sell
468,933
-13,697
-3% -$710K 1.96% 19
2018
Q1 		$22.1M Sell
482,630
-63,839
-12% -$2.66M 1.63% 28
2017
Q4 		$21.8M Sell
546,469
-442,371
-45% -$17.5M 1.6% 28
2017
Q3 		$39.6M Sell
988,840
-124,415
-11% -$5.38M 2.97% 9
2017
Q2 		$48M Sell
1,113,255
-369,280
-25% -$13.1M 3.42% 3
2017
Q1 		$46.4M Buy
1,482,535
+40,131
+3% +$1.08M 3.37% 2
2016
Q4 		$36.4M Sell
1,442,404
-49,431
-3% -$1.1M 2.59% 4
2016
Q3 		$36.9M Sell
1,491,835
-824,727
-36% -$18.7M 2.65% 2
2016
Q2 		$47.2M Sell
2,316,562
-94,024
-4% -$1.67M 2.91% 5
2016
Q1 		$36.8M Buy
2,410,586
+425,608
+21% +$5.55M 2.25% 15
2015
Q4 		$26.7M Buy
1,984,978
+424,525
+27% +$6.57M 1.57% 28
2015
Q3 		$21.9M Buy
1,560,453
+157,939
+11% +$2.94M 1.23% 37
2015
Q2 		$23.8M Buy
1,402,514
+1,251,014
+826% +$17.8M 1.16% 33
2015
Q1 		$1.83M Buy
151,500
+3,370
+2% +$31.8K 0.09% 74
2014
Q4 		$1.23M Buy
+148,130
New +$1.24M 0.06% 81

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
ACM
Ashford Capital Management Wilmington, Delaware $809M AUM 35.1% 1-Year Est. Return

Ranger Investment Management's SUPN Position: Q3 2019 in Review

Ranger Investment Management sold out of Supernus Pharmaceuticals (SUPN) in Q3 2019, closing a stake of 468,796 shares — an estimated $15.5M sold.

Ranger Investment Management first reported a position in SUPN in Q4 2014 and held it in 19 quarters. The position peaked at $48M in Q2 2017. 243 funds tracked by Wall St. Rank hold SUPN as of Q3 2019.

  • Ranger Investment Management reported no remaining Supernus Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • Ranger Investment Management sold 468,796 Supernus Pharmaceuticals shares in Q3 2019, an estimated $15.5M.
  • Ranger Investment Management first reported a position in Supernus Pharmaceuticals in Q4 2014 and held it in 19 quarters.
  • Ranger Investment Management's Supernus Pharmaceuticals position peaked at $48M in Q2 2017.
  • 243 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q3 2019.

Based on Ranger Investment Management's 13F filing for Q3 2019, filed 14 Nov 2019.